Normal Balloon Catheter Market Value to Reach US$ 2,000 Mn by 2022-end

Dublin 2, Ireland, 2018-Feb-09 — /EPR Network/ — Rising prevalence of patients with end stage renal disease, and growth in interventional cardiology will facilitate the utilization of the normal balloon catheters. Normal balloon catheter manufacturers are focusing on the development of cost-effective and more efficient solutions. This Fact.MR report analyzes the expansion of global normal balloon catheter market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.

The scope of Fact.MR’s report is to analyze the global normal balloon catheter market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global normal balloon catheter market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to normal balloon catheter.

Request Free Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=147

Trends Being Observed in the Global Normal Balloon Catheter Market

1.  Rise in interventional cardiology is facilitating use of the normal balloon catheters

2.   Surging prevalence of patients with end stage renal disease have been fuelling demand for normal balloon catheters

3.   The number of people undergoing renal replacement therapy is increasing, thereby fuelling growth of the normal balloon catheter market

Normal balloon catheter sales in cardiac catheterization laboratories will register the fastest expansion over the forecast period, on the basis of end-users. In addition, hospitals are expected to retain their dominance in the global market for normal balloon catheters.

Europe to Account for the Largest Revenue Share of the Market during 2017 to 2022

In terms of revenues, Europe will account for the largest share of the market during the forecast period. Europe will continue to be the most lucrative market for normal balloon catheter. Sales of normal balloon catheter in Asia-Pacific excluding Japan (APEJ) will register the highest CAGR through 2022. In contrast, sales of normal balloon catheter in North America will exhibit the lowest CAGR in the market through 2022.

By indication, coronary artery disease will remain dominant in the global market, with sales poised to surpass US$ 1,000 Mn in revenues by 2022-end. Approximately three-fourth revenue share of the market will be accounted by sales of normal balloon catheter for coronary artery disease during 2017 to 2022.

Browse Full Report with TOC- https://www.factmr.com/report/147/normal-balloon-catheter-market

Hospitals to Remain the Largest End-Users of Normal Balloon Catheter

Sales of normal balloon catheter in cardiac catheterization laboratories are expected to exhibit the fastest expansion through 2022, based on end-users. Hospitals will remain the largest end-users of normal balloon catheter throughout the forecast period.

Nylon will continue to be the preferred raw material for manufacturing normal balloon catheter. Nearly half revenue share of the market will be accounted by nylon, based on raw material. However, sales of polyurethane for production of normal balloon catheter will register a comparatively higher CAGR than sales of nylon through 2022.

Competition Tracking

Key players profiled in Fact.MR’s report include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, MicroPort Scientific Corporation, B. Braun Melsungen AG, Meril Life Sciences Pvt. Ltd., Hexacath, Tokai Medical Products Inc., Cook Medical INC, Cordis Corporation, and BIOTRONIK SE & Co. KG.

Check Discount- https://www.factmr.com/connectus/sample?flag=D&rep_id=147

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized  Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/